Pura Vida Investments’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Pura Vida Investments’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-24,100	Closed	-$121K	–	151
2018 Q2	$121K	Hold	24,100	–	–	0.05%	92
2018 Q1	$124K	Hold	24,100	–	–	0.07%	66
2017 Q4	$145K	Hold	24,100	–	–	0.06%	69
2017 Q3	$134K	Hold	24,100	–	–	0.04%	76
2017 Q2	$112K	Hold	24,100	–	–	0.04%	66
2017 Q1	$119K	Sell	24,100 -112,900	-82%	-$1.09M	0.04%	76
2016 Q4	$1.52M	Hold	137,000	–	–	0.56%	47
2016 Q3	$1.27M	Buy	137,000 +35,000	+34%	+$293K	0.39%	67
2016 Q2	$648K	Hold	102,000	–	–	0.28%	62
2016 Q1	$665K	Hold	102,000	–	–	0.3%	63
2015 Q4	$827K	Hold	102,000	–	–	0.35%	62
2015 Q3	$748K	Buy	+102,000	New	+$1.04M	0.43%	53

Other funds holding FOMX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Pura Vida Investments's FOMX Position: Q3 2018 in Review

Pura Vida Investments sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2018, closing a stake of 24,100 shares — an estimated $121K sold.

Pura Vida Investments first reported a position in FOMX in Q3 2015 and held it in 12 quarters. The position peaked at $1.52M in Q4 2016. 75 funds tracked by Wall St. Rank hold FOMX as of Q3 2018.

Pura Vida Investments reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2018 after selling out during the quarter.
Pura Vida Investments sold 24,100 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2018, an estimated $121K.
Pura Vida Investments first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2015 and held it in 12 quarters.
Pura Vida Investments's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.52M in Q4 2016.
75 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2018.

Based on Pura Vida Investments's 13F filing for Q3 2018, filed 14 Nov 2018.